OliX Moves Into Spotlight Amid Strong RNAi Interest, New Platform

Big Pharma Deals To Follow?

 
• By Jung Won Shin
  
DNA_Spiral
OliX A Potential Dark Horse In RNAi Therapeutics? • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from South Korea

More from Focus On Asia